Clinical trialPhase 2Recruiting
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
A Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma
- Outcome
- Ongoing
- Phase
- Phase 2
- Status
- Recruiting
- Study type
- Interventional
- Start
- April 2016
- Expected end
- October 2040
- Enrollment
- 60 participants
- Sites
- 4
- Primary outcomes
- Overall survival at 12 months after radiation therapy
- Sponsor
- Network
- Results posted
- No
- Last update
- 29 September 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 3
- Builds on itDose-escalated proton therapy with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline… DOI 10.21037/jgo-21-593↗
- BackgroundMapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adj… DOI 10.1016/j.ijrobp.2013.09.005↗
- BackgroundSurvival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. DOI 10.1245/s10434-011-1900-3↗